Insurance, Medicare and self-pay pricing, and the monthly math behind each.
11% of US adults take a GLP-1 and half say it is hard to afford. The time-horizon math behind employer, Medicare and state coverage, in plain terms.
Employers are dropping GLP-1 coverage. See how to check any plan's drug list before open enrollment closes, and what the conditions mean.
Three diagnoses disqualify you from Medicare's $50 GLP-1 price. See why, what a Part D copay really costs, and how cash pay compares.
SB 1089 passed the California Legislature and awaits the governor. See what it actually does, what it does not do, and what to watch next.
Turnkey platforms let almost anyone launch a GLP-1 clinic, one vendor says daily. See why prices fell, where the risk sits, and the 3 names to ask for
The FTC sued Hims & Hers over subscription billing and health data. See what it alleges, the company's response, and what to check on your account.
2027 marketplace enrollment runs November 1 to January 15. December 15 is the cutoff for coverage that starts January 1.
A rejected Medicare GLP-1 Bridge claim is usually a paperwork step, not a denial. See the four reasons and what to ask your pharmacy.
Do you need a rejected claim before the Medicare GLP-1 Bridge prior authorization? What CMS actually says, and how the process really works.
Michigan Medicaid now limits GLP-1 weight-loss coverage to BMI 40+ with strict rules. See who still qualifies, what changed, and your options.
GLP-1 use hit a new high in 2026: about 11% of US adults now take one. See who is using them, the brand vs compounded split, and what it means.
Brand GLP-1 cash prices are falling fast. See what Ozempic, Wegovy, and Zepbound cost now, why, and whether your own bill will drop.
